Fulgent Genetics, Inc.
For the period ended Sep 30, 2026. Filed Nov 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 5, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Stockholders’ Equity
| Fulgent Stockholders’ Equity | ||||||||
|---|---|---|---|---|---|---|---|---|
| Shares (1) | Amount | Additional Paid-In Capital | Accumulated Other Comprehensive(Loss) Income | Retained Earnings | Fulgent Stockholders’ Equity | Noncontrolling Interest | Total Equity | |
| Balance at December 31, 2025 | 31,081 | $3 | $574,520 | $7,512 | $529,954 | $1,111,989 | $(5,274) | $1,106,715 |
| Equity-based compensation | — | — | 9,890 | — | — | 9,890 | — | 9,890 |
| Exercise of common stock options | 24 | — | 9 | — | — | 9 | — | 9 |
| Restricted stock awards | 540 | 1 | — | — | — | 1 | — | 1 |
| Common stock withholding for employee tax obligations | (195) | — | (4,200) | — | — | (4,200) | — | (4,200) |
| Repurchase of common stock | (2,599) | — | (40,078) | — | — | (40,078) | — | (40,078) |
| Other comprehensive (loss) income, net | — | — | — | (2,976) | — | (2,976) | 67 | (2,909) |
| Net loss | — | — | — | — | (24,826) | (24,826) | (448) | (25,274) |
| Balance at March 31, 2026 | 28,851 | $4 | $540,141 | $4,536 | $505,128 | $1,049,809 | $(5,655) | $1,044,154 |
| Equity-based compensation | — | — | 8,624 | — | — | 8,624 | — | 8,624 |
| Exercise of common stock options | 5 | — | 2 | — | — | 2 | — | 2 |
| Restricted stock awards | 201 | — | — | — | — | — | — | — |
| Common stock withholding for employee tax obligations | (19) | — | (334) | — | — | (334) | — | (334) |
| Repurchase of common stock | (1,523) | — | (24,336) | — | — | (24,336) | — | (24,336) |
| Other comprehensive (loss) income, net | — | — | — | (2,616) | — | (2,616) | 211 | (2,405) |
| Net loss | — | — | — | — | (29,530) | (29,530) | (189) | (29,719) |
| Balance at June 30, 2026 | 27,515 | $4 | $524,097 | $1,920 | $475,598 | $1,001,619 | $(5,633) | $995,986 |
| Equity-based compensation | — | — | 8,120 | — | — | 8,120 | — | 8,120 |
| Exercise of common stock options | — | — | — | — | — | — | — | — |
| Restricted stock awards | 282 | — | — | — | — | — | — | — |
| Common stock withholding for employee tax obligations | (19) | — | (380) | — | — | (380) | — | (380) |
| Repurchase of common stock | (15) | — | (208) | — | — | (208) | — | (208) |
| Other comprehensive (loss) income, net | — | — | — | (5,445) | — | (5,445) | 39 | (5,406) |
| Contingently issuable shares in a business combination(1) | — | — | (65) | — | — | (65) | — | (65) |
| Net loss | — | — | — | — | (13,152) | (13,152) | (187) | (13,339) |
| Balance at September 30, 2026 | 27,763 | $4 | $531,564 | $(3,525) | $462,446 | $990,489 | $(5,781) | $984,708 |
(1)The Company agreed to issue up to 292,682 shares of the Company’s common stock in the acquisition of ANP Technologies, Inc., or ANP, upon achieving certain cash receipts. $5.7 million represented the fair value of the shares on the ANP acquisition date (as defined below). As of September 30, 2026, certain milestones have been met, and 143,023 shares of the Company's common stock were issued in October 2026. A portion of the earnout was settled in cash, rather than shares of common stock, for holders that were not accredited investors, as required by the agreement and plan of merger, as amended, by and among the Company, ANP, and other parties thereto, or the ANP Merger Agreement, which was also paid in October 2026. The $65,000 reflects the reclassification to a liability of the portion of the first milestone settled in cash. Refer to Note 18. Subsequent Events for additional details.146,341 shares of the Company's common stock remain issuable dependent on the achievement of additional milestones.
Condensed Consolidated Statements of Stockholders’ Equity
| Fulgent Stockholders’ Equity | ||||||||
|---|---|---|---|---|---|---|---|---|
| Shares | Amount | Additional Paid-In Capital | Accumulated Other ComprehensiveIncome (Loss) | Retained Earnings | Fulgent Stockholders’ Equity | Noncontrolling Interest | Total Equity | |
| Balance at December 31, 2024 | 30,841 | $3 | $543,126 | $(368) | $590,467 | $1,133,228 | $(4,069) | $1,129,159 |
| Equity-based compensation | — | — | 10,550 | — | — | 10,550 | — | 10,550 |
| Restricted stock awards | 360 | — | — | — | — | — | — | — |
| Common stock withholding for employee tax obligations | (111) | — | (1,887) | — | — | (1,887) | — | (1,887) |
| Repurchase of common stock | (469) | — | (7,886) | — | — | (7,886) | — | (7,886) |
| Other comprehensive income, net | — | — | — | 4,703 | — | 4,703 | 30 | 4,733 |
| Net loss | — | — | — | — | (11,530) | (11,530) | (369) | (11,899) |
| Balance at March 31, 2025 | 30,621 | $3 | $543,903 | $4,335 | $578,937 | $1,127,178 | $(4,408) | $1,122,770 |
| Equity-based compensation | — | — | 10,039 | — | — | 10,039 | — | 10,039 |
| Restricted stock awards | 182 | — | — | — | — | — | — | — |
| Common stock withholding for employee tax obligations | (18) | — | (345) | — | — | (345) | — | (345) |
| Repurchase of common stock | (177) | — | (2,998) | — | — | (2,998) | — | (2,998) |
| Other comprehensive income (loss), net | — | — | — | 1,663 | — | 1,663 | (237) | 1,426 |
| Net loss | — | — | — | — | (18,957) | (18,957) | (299) | (19,256) |
| Balance at June 30, 2025 | 30,608 | $3 | $550,599 | $5,998 | $559,980 | $1,116,580 | $(4,944) | $1,111,636 |
| Equity-based compensation | — | — | 9,717 | — | — | 9,717 | — | 9,717 |
| Restricted stock awards | 264 | — | — | — | — | — | — | — |
| Common stock withholding for employee tax obligations | (18) | — | (357) | — | — | (357) | — | (357) |
| Contingently issuable shares in a business combination (1) | — | — | 5,731 | — | — | 5,731 | — | 5,731 |
| Other comprehensive income, net | — | — | — | 825 | — | 825 | 31 | 856 |
| Net loss | — | — | — | — | (6,608) | (6,608) | (218) | (6,826) |
| Balance at September 30, 2025 | 30,854 | $3 | $565,690 | $6,823 | $553,372 | $1,125,888 | $(5,131) | $1,120,757 |
(1)The Company agreed to issue up to 292,682 shares of the Company’s common stock in the acquisition of ANP, upon achieving certain cash receipts. $5.7 million represented the fair value of the shares on the ANP acquisition date.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.